Clinical trial

Tailored Neoadjuvant Chemotherapy for Stage II/III Breast Cancer With Tumor Size More Than 2 cm

NCT00776724

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2008-05-29

PhasePHASE3

Study timeline

Study start (actual)2008-05-29Date precision: day

Registry last updated2019-05-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Chemotherapyunresolved

Interventions

Taxotere , EpirubicinDRUG

E-HDFL,EP,TE,N-HDFL,NP,T-HDFL,TPDRUG

Sponsors & collaborators

National Taiwan University Hospitallead sponsor

Mapped research locations

TaipeiTaiwan1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00776724 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.